期刊
SMALL
卷 17, 期 28, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.202100546
关键词
CRISPR; Cas9; Duchenne muscular dystrophy; gene editing; nanosubstrate-mediated delivery; supramolecular nanoparticles
类别
资金
- National Institutes of Health [R21EB016270]
- Office of the Director, NIH [DP5OD028181]
- NIH Common Fund through a NIH Director's Early Independence Award
- National Institute of Dental and Craniofacial Research
CRISPR/Cas9 technology offers a versatile solution for treating genetic diseases through efficient and precise gene editing. A nonviral delivery strategy involving encapsulating Cas9·sgRNA ribonucleoprotein complexes into supramolecular nanoparticles has shown promise in targeted cell delivery, demonstrating efficient gene disruption in various cell types.
The clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (CRISPR/Cas9) is an efficient and precise gene-editing technology that offers a versatile solution for establishing treatments directed at genetic diseases. Currently, CRISPR/Cas9 delivery into cells relies primarily on viral vectors, which suffer from limitations in packaging capacity and safety concerns. These issues with a nonviral delivery strategy are addressed, where Cas9 center dot sgRNA ribonucleoprotein (RNP) complexes can be encapsulated into supramolecular nanoparticles (SMNP) to form RNP subset of SMNPs, which can then be delivered into targeted cells via supramolecular nanosubstrate-mediated delivery. Utilizing the U87 glioblastoma cell line as a model system, a variety of parameters for cellular-uptake of the RNP-laden nanoparticles are examined. Dose- and time-dependent CRISPR/Cas9-mediated gene disruption is further examined in a green fluorescent protein (GFP)-expressing U87 cell line (GFP-U87). The utility of an optimized SMNP formulation in co-delivering Cas9 protein and two sgRNAs that target deletion of exons 45-55 (708 kb) of the dystrophin gene is demonstrated. Mutations in this region lead to Duchenne muscular dystrophy, a severe genetic muscle wasting disease. Efficient delivery of these gene deletion cargoes is observed in a human cardiomyocyte cell line (AC16), induced pluripotent stem cells, and mesenchymal stem cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据